Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | SVP, Clinical Solutions | July 22, 2026 | July 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QUEST DIAGNOSTICS INC
Report date July 22, 2026 · Filed July 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,557 |
Reported balance
After 2026-07-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-22 · Other · Acquired 37 · Balance 13,557 F1: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 358 |
Reported balance
Holding disclosure · report date 2026-07-22 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 358 |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 1,691 |
Reported balance
Holding disclosure · report date 2026-07-22 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,691 F3: These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
F2: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
F3: These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 23, 2023 Filed Oct 26, 2023 22:17 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 30 | $122.86 | $3,685.86 |
DisclosureSEC source: 0001022079-23-000164 · wk-form4_1698358629.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,358 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
| August 15, 2023 Filed Aug 17, 2023 20:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 74 | $135.23 | $10,007.02 |
DisclosureSEC source: 0001022079-23-000141 · wk-form4_1692304787.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,294 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 20:43 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 25 | $144.59 | $3,614.80 |
DisclosureSEC source: 0001022079-23-000139 · wk-form4_1690490619.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,355 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 21:47 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 25 | $143.08 | $3,576.98 |
DisclosureSEC source: 0001022079-23-000085 · wf-form4_168245926446885.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,295 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 583 | $147.86 | $86,202.38 |
DisclosureSEC source: 0001022079-23-000066 · wf-form4_167831125235378.xml · nonDerivative · entry 2 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,241 F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,985 | $147.86 | $293,502.10 |
DisclosureSEC source: 0001022079-23-000066 · wf-form4_167831125235378.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,824 F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2020, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:40 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 65 | $140.69 | $9,144.85 |
DisclosureSEC source: 0001022079-23-000044 · wf-form4_167787957832714.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,839 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:45 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 8,270 | $0.00 Strike: $143.33 | $0.00 |
DisclosureSEC source: 0001022079-23-000032 · wf-form4_167753428265779.xml · derivative · entry 5 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,270 Underlying: Common Stock · 8,270 shares Expires 2033-02-23 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:45 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 2,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-23-000032 · wf-form4_167753428265779.xml · nonDerivative · entry 2 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,904 F2 · security: Represents an award of restricted share units. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:45 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 195 | $147.86 | $28,832.70 |
DisclosureSEC source: 0001022079-23-000032 · wf-form4_167753428265779.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,810 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 13 | $146.75 | $1,907.70 |
DisclosureSEC source: 0001022079-23-000010 · wf-form4_167546012705026.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,005 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.